Free Submission Public Relations &
Deutsch English


New market study, "Abbott Laboratories - SWOT, Strategy and Corporate Finance Report", has been published

Print article Print article
2014-01-07 22:33:38 - Fast Market Research recommends "Abbott Laboratories - SWOT, Strategy and Corporate Finance Report" from MarketLine, now available

Abbott Laboratories - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.


* Detailed information on Abbott Laboratories required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Abbott Laboratories in the form of a SWOT analysis
* An in-depth view of the business model of Abbott Laboratories including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Abbott Laboratories

Intelligence on Abbott Laboratoriesnv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Abbott Laboratories, such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- ..


Abbott Laboratories (Abbott or 'the company') is a diversified healthcare company with a portfolio diagnostic products, medical devices, nutritionals and branded generic pharmaceuticals. The company markets its products in several countries, with major operations in the US, the Netherlands, Germany, Japan, Italy, France, Canada, the UK and Spain. It is headquartered in Abbott Park, Illinois, and employs about 70,000 people. In January 2013, Abbott completed the separation of its research-based pharmaceuticals business through the distribution of the issued and outstanding common stock of AbbVie Inc. (AbbVie) to Abbott's shareholders. AbbVie was formed to hold Abbott's research-based pharmaceuticals business and, as a result of the distribution, is now an independent public company trading under the symbol 'ABBV' on the New York Stock Exchange. Abbott recorded revenues of $39,873.9 million during the financial year ended March 2012 (FY2012), an increase of 2.6% over FY2011. The operating profit of the company was $8,084.5 million in FY2012, an increase of 40.6% over FY2011. The net profit was $5,962.9 million in FY2012, an increase of 26.1% over FY2011.

Reasons to Purchase:

* Gain understanding of Abbott Laboratories and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Abbott Laboratories as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Abbott Laboratories's business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
Abbott Laboratories: Company Overview
Abbott Laboratories: Overview and Key Facts
Abbott Laboratories: Overview
Abbott Laboratories: Key Facts
Abbott Laboratories: Key Employees
Abbott Laboratories: Key Employee Biographies
Abbott Laboratories: Major Products and Services
Abbott Laboratories: Company History
Abbott Laboratories: Management Statement
Abbott Laboratories: Locations and Subsidiaries
Abbott Laboratories: Key Competitors
Abbott Laboratories: Company Analysis
Abbott Laboratories: Business Description
Abbott Laboratories: SWOT Analysis
Abbott Laboratories: SWOT Overview
Abbott Laboratories: Strengths
Abbott Laboratories: Weaknesses
Abbott Laboratories: Opportunities
Abbott Laboratories: Threats
Abbott Laboratories: Corporate Financial Deals Activity
Abbott Laboratories: Financial Deals Overview
Abbott Laboratories: Targets and Partners
Abbott Laboratories: Top Deals 2009 - 2013YTD*
Abbott Laboratories: Advisors
Abbott Laboratories: Top Legal Advisors
Abbott Laboratories: Top Financial Advisors
Abbott Laboratories: Mergers and Acquisitions
Abbott Laboratories: Corporate Venturing
Abbott Laboratories: Capital Raising
Abbott Laboratories: Partnership
Abbott Laboratories: Divestments
Abbott Laboratories: Recent Developments
Abbott Laboratories: News and Events Summary
Abbott Laboratories: Business Expansion
Abbott Laboratories: Financial Deals
Abbott Laboratories: Regulatory and Legal Events
Abbott Laboratories: Research & Development
Abbott Laboratories: Strategy and Operations
Contact Us
About Datamonitor

List of Tables

Table 1: Abbott Laboratories: Key Facts
Table 2: Abbott Laboratories: Key Employees
Table 4: Abbott Laboratories: Key Competitors
Table 5: Abbott Laboratories: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Abbott Laboratories: M&A Activity by Geography (TTM*)
Table 7: Abbott Laboratories: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 8: Abbott Laboratories: M&A Average Deal Size - Value (US$m)
Table 9: Abbott Laboratories: Targets and Partners
Table 10: Abbott Laboratories: Top Deals 2009 - 2013YTD*
Table 11: Abbott Laboratories: Legal Advisor Ranking by Value (US$m)

Full Table of Contents is available at:

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact